PSTI - プルリステム・セラピュ―ティクス (Pluristem Therapeutics Inc.)

PSTIのニュース

   Cathie Woods ARK Invest Sells 194,000 Shares of Pluristem Therapeutics  2021/06/05 11:53:36 24/7 Wall street
   Pluristem CEO touts a new generation of medical treatments  2021/06/02 10:31:52 The Jerusalem Post
Yaky Yanay at Dubai conference: They put Israel on the map as an island of innovation
   Financings for May 25, 2021  2021/05/25 16:00:00 BioWorld
Med-tech firms raising money in public or private financings, including: Emboline, Noom, Pluristem, Rapid Medical.
   Pluristem Stock is Trading Higher After 20M Non-Dilutive Funding from European Investment Bank  2021/05/25 12:48:36 Benzinga
Pluristem Therapeutics Inc (NASDAQ: PSTI ) has received 20 million (approximately $24 million) from the European Investment Bank (EIB), the first disbursement of three tranches of funding. The disbursement reflects that Pluristem has achieved a key milestone in a previously Full story available on Benzinga.com
   Pluristem rises 7% following 20M funding from European Investment Bank  2021/05/25 12:01:25 Seeking Alpha
   Cathie Woods ARK Invest Sells 194,000 Shares of Pluristem Therapeutics  2021/06/05 11:53:36 24/7 Wall street
   Pluristem CEO touts a new generation of medical treatments  2021/06/02 10:31:52 The Jerusalem Post
Yaky Yanay at Dubai conference: They put Israel on the map as an island of innovation
   Financings for May 25, 2021  2021/05/25 16:00:00 BioWorld
Med-tech firms raising money in public or private financings, including: Emboline, Noom, Pluristem, Rapid Medical.
   Pluristem Stock is Trading Higher After 20M Non-Dilutive Funding from European Investment Bank  2021/05/25 12:48:36 Benzinga
Pluristem Therapeutics Inc (NASDAQ: PSTI ) has received 20 million (approximately $24 million) from the European Investment Bank (EIB), the first disbursement of three tranches of funding. The disbursement reflects that Pluristem has achieved a key milestone in a previously Full story available on Benzinga.com
   Pluristem rises 7% following 20M funding from European Investment Bank  2021/05/25 12:01:25 Seeking Alpha
   The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron  2021/05/12 12:57:17 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ: HOOK ) Novo Nordisk A/S (NYSE: NVO ) West Pharmaceutical Services, Inc. (NYSE: WST ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows May 11) 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT ) 4D pharma plc (NASDAQ: LBPS ) Acutus Medical, Inc. (NASDAQ: AFIB ) Adagene Inc. (NASDAQ: ADAG ) Adaptive Biotechnologies Corporation (NASDAQ: ADPT ) ADC Therapeutics SA (NYSE: ADCT ) Agile Therapeutics, Inc. (NASDAQ: AGRX ) Akouos, Inc. (NASDAQ: AKUS ) (reacted to presentation of non-clinical data on gene therapy candidates at the American Society of Gene and Cell Therapy meeting) Akoya Biosciences, Inc. (NASDAQ: AKYA ) Aprea Therapeutics, Inc. (NASDAQ: APRE ) Aptinyx Inc. (NASDAQ: APTX ) Aquestive Therapeutics, Inc. (NASDAQ: AQST ) ARCA biopharma, Inc. (NASDAQ: ABIO ) Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT ) (reacted to its first-quarter results) Assembly Biosciences, Inc.
   Pluristem Stock Is Trading Higher As PLX-R18 Shows Regenerative Potential In Patients After Bone Marrow Transplant  2021/04/29 13:42:14 Benzinga
Pluristem Therapeutics Inc (NASDAQ: PSTI ) has reported positive topline results from Phase 1 study evaluating intramuscular injections of PLX-R18 in subjects with incomplete hematopoietic recovery following Hematopoietic Cell Transplantation (HCT). The results demonstrate that PLX-R18 has the potential to stimulate the implanted hematopoietic cells to … Full story available on Benzinga.com
   Mesenchymal Stem Cells Market | Pluristem Therapeutics, LonzaThermo, Fisher, ATCC, Bio-Techne, MilliporeSigma, Genlantis, Celprogen  2021/03/17 11:07:44 OpenPR
Mesenchymal Stem Cells Market report is an in-depth analysis study offered which explains necessary aspects like competition, segmentation, and regional growth in excessive detail. As a part of competitive analysis, the analysis study includes thorough company identification of leading players
   Mesenchymal Stem Cells Market Analysis By Main Players Pluristem Therapeutics, LonzaThermo, Fisher, ATCC, Bio-Techne, MilliporeSigma, Genlantis, Celprogen, Cell Applications, PromoCell GmbH,  2021/01/25 08:41:41 OpenPR
The “Mesenchymal Stem Cells Market” Research Report 2020-2027 is a specialized and in-depth study of the Mesenchymal Stem Cells industry with a focus on the global market trend. The report aims to provide an overview of global Mesenchymal Stem Cells
   Mesenchymal Stem Cells Market - Pluristem Therapeutics, LonzaThermo, Fisher, ATCC, Bio-Techne, MilliporeSigma, Genlantis, Celprogen, Cell Applications, PromoCell GmbH, Cyagen Biosciences, Human Longevity Inc.  2020/10/13 09:13:30 OpenPR
Global Mesenchymal Stem Cells Market Analysis, Size, Share, Outlook and Forecast to 2020-2027 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific). The market attractiveness

calendar